Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
53 rows where has_cryoEM = 1, surface_class = "A2_pm_peripheral" and tier = "Tier 1" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: aptamer_count_pubmed
tier 1
- Tier 1 · 53 ✖
surface_class 1
- A2_pm_peripheral · 53 ✖
has_structure 1
- 1 53
has_cryoEM 1
- 1 · 53 ✖
has_activation_state_pdb_pair 1
- 0 53
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | Tier 1 | 0.794 | 1 | A2_pm_peripheral | 100 | 97.06 | 1 | 0 | 0 | 0 | 1 | intellectual disability, autosomal dominant 42 | 0.8462216225099116 | |||
| P06737 | PYGL | Glycogen phosphorylase, liver form | Tier 1 | 0.787 | 1 | A2_pm_peripheral | 19 | 92.69 | 1 | 0 | 0 | 0 | 1 | glycogen storage disease VI | 0.8220063508118274 | |||
| P49770 | EIF2B2 | Translation initiation factor eIF2B subunit beta | Tier 1 | 0.787 | 1 | A2_pm_peripheral | 25 | 86.56 | 1 | 0 | 0 | 0 | 1 | CACH syndrome | 0.824634396744653 | |||
| P21333 | FLNA | Filamin-A | Tier 1 | 0.786 | 1 | A2_pm_peripheral | 26 | 76.56 | 1 | 0 | 0 | 0 | 1 | Melnick-Needles syndrome | 0.8200516896124751 | |||
| Q01831 | XPC | DNA repair protein complementing XP-C cells | Tier 1 | 0.782 | 1 | A2_pm_peripheral | 14 | 66.56 | 1 | 0 | 0 | 0 | 1 | Xeroderma pigmentosum complementation group C | 0.8056391472748724 | |||
| P01137 | TGFB1 | Transforming growth factor beta-1 proprotein | Tier 1 | 0.78 | 1 | A2_pm_peripheral | 20 | 79.56 | 1 | 0 | 1 | 4 | 38132522, 32370304, 16775010, 11856769 | 1 | Camurati-Engelmann disease | 0.7995305374459716 | ||
| Q92743 | HTRA1 | Serine protease HTRA1 | Tier 1 | 0.768 | 1 | A2_pm_peripheral | 18 | 83.25 | 1 | 0 | 1 | 1 | 31988066 | 1 | cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | 0.7611877816680132 | ||
| Q9BYI3 | HYCC1 | Hyccin | Tier 1 | 0.766 | 1 | A2_pm_peripheral | 5 | 67.75 | 1 | 0 | 0 | 0 | 1 | Hypomyelination - congenital cataract | 0.7528702184568328 | |||
| P35221 | CTNNA1 | Catenin alpha-1 | Tier 1 | 0.765 | 1 | A2_pm_peripheral | 10 | 82.94 | 1 | 0 | 1 | 2 | 40265971 | 1 | Butterfly-shaped pigment dystrophy | 0.7487735496199569 | ||
| P13797 | PLS3 | Plastin-3 | Tier 1 | 0.757 | 1 | A2_pm_peripheral | 6 | 88.75 | 1 | 0 | 0 | 0 | 1 | X-linked osteoporosis with fractures | 0.721756781312783 | |||
| P84077 | ARF1 | ADP-ribosylation factor 1 | Tier 1 | 0.755 | 1 | A2_pm_peripheral | 36 | 85.94 | 1 | 0 | 1 | 3 | 30965174, 11320245 | 1 | periventricular nodular heterotopia 8 | 0.7173626622431929 | ||
| P07357 | C8A | Complement component C8 alpha chain | Tier 1 | 0.75 | 1 | A2_pm_peripheral | 11 | 78.69 | 1 | 0 | 0 | 0 | 1 | Immunodeficiency due to a late component of complements deficiency | 0.700643416115894 | |||
| Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Tier 1 | 0.749 | 1 | A2_pm_peripheral | 39 | 69.75 | 1 | 0 | 1 | 2 | 41290466, 35919280 | 1 | immunodeficiency 57 | 0.698121745966467 | ||
| P50148 | GNAQ | Guanine nucleotide-binding protein G(q) subunit alpha | Tier 1 | 0.748 | 1 | A2_pm_peripheral | 30 | 93.0 | 1 | 0 | 1 | 1 | 40015005 | 1 | Sturge-Weber syndrome | 0.6941111530708174 | ||
| O95786 | RIGI | Antiviral innate immune response receptor RIG-I | Tier 1 | 0.735 | 1 | A2_pm_peripheral | 44 | 85.19 | 1 | 0 | 1 | 6 | 34487794, 33253193, 32946572, 31600868, 26018150, 22127865 | 1 | Singleton-Merten dysplasia | 0.6485708110478319 | ||
| P23921 | RRM1 | Ribonucleoside-diphosphate reductase large subunit | Tier 1 | 0.724 | 1 | A2_pm_peripheral | 12 | 92.25 | 1 | 0 | 1 | 1 | 21955496 | 1 | non-small cell lung carcinoma | 0.6122881671315019 | ||
| P62987 | UBA52 | Ubiquitin-ribosomal protein eL40 fusion protein | Tier 1 | 0.712 | 1 | A2_pm_peripheral | 30 | 93.5 | 1 | 0 | 0 | 0 | 1 | HIV infection | 0.5745684844613109 | |||
| P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Tier 1 | 0.706 | 1 | A2_pm_peripheral | 21 | 98.12 | 1 | 0 | 1 | 11 | 39832592, 39429683, 35821507, 28131717, 26310631, 23215008, 37500700, 16115199 | 1 | neurodegenerative disease | 0.55307368855439 | ||
| Q8NFH5 | NUP35 | Nucleoporin NUP35 | Tier 1 | 0.702 | 1 | A2_pm_peripheral | 5 | 63.19 | 1 | 0 | 0 | 0 | 1 | influenza | 0.5409211817593593 | |||
| Q13033 | STRN3 | Striatin-3 | Tier 1 | 0.701 | 1 | A2_pm_peripheral | 4 | 67.5 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5377902198332467 | |||
| O75143 | ATG13 | Autophagy-related protein 13 | Tier 1 | 0.701 | 1 | A2_pm_peripheral | 13 | 63.84 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5360512349298453 | |||
| Q6IAA8 | LAMTOR1 | Ragulator complex protein LAMTOR1 | Tier 1 | 0.7 | 1 | A2_pm_peripheral | 22 | 80.12 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5318107016634962 | |||
| P49662 | CASP4 | Caspase-4 | Tier 1 | 0.692 | 1 | A2_pm_peripheral | 9 | 78.38 | 1 | 0 | 0 | 0 | 1 | bacterial disease | 0.5062783346658307 | |||
| Q9UBL3 | ASH2L | Set1/Ash2 histone methyltransferase complex subunit ASH2 | Tier 1 | 0.691 | 1 | A2_pm_peripheral | 27 | 75.25 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.5019091999413609 | |||
| P49327 | FASN | Fatty acid synthase | Tier 1 | 0.68 | 1 | A2_pm_peripheral | 34 | 85.44 | 1 | 0 | 1 | 1 | 41854184 | 1 | dengue disease | 0.46815584653391107 | ||
| P83881 | RPL36A | Large ribosomal subunit protein eL42 | Tier 1 | 0.679 | 1 | A2_pm_peripheral | 30 | 94.31 | 1 | 0 | 0 | 0 | 1 | influenza | 0.4619748183558772 | |||
| Q5VZK9 | CARMIL1 | F-actin-uncapping protein LRRC16A | Tier 1 | 0.677 | 1 | A2_pm_peripheral | 3 | 67.38 | 1 | 0 | 0 | 0 | 1 | schizophrenia | 0.45718735748281236 | |||
| Q86TV6 | TTC7B | Tetratricopeptide repeat protein 7B | Tier 1 | 0.673 | 1 | A2_pm_peripheral | 5 | 85.0 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.4430588960838045 | |||
| Q16763 | UBE2S | Ubiquitin-conjugating enzyme E2 S | Tier 1 | 0.673 | 1 | A2_pm_peripheral | 9 | 80.69 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.44489727765466 | |||
| Q16555 | DPYSL2 | Dihydropyrimidinase-related protein 2 | Tier 1 | 0.671 | 1 | A2_pm_peripheral | 15 | 90.25 | 1 | 0 | 0 | 0 | 1 | hypertension | 0.4377422749119531 | |||
| P61077 | UBE2D3 | Ubiquitin-conjugating enzyme E2 D3 | Tier 1 | 0.667 | 1 | A2_pm_peripheral | 46 | 96.38 | 1 | 0 | 0 | 0 | 1 | hypertension | 0.4222295115574527 | |||
| P04899 | GNAI2 | Guanine nucleotide-binding protein G(i) subunit alpha-2 | Tier 1 | 0.665 | 1 | A2_pm_peripheral | 34 | 94.06 | 1 | 0 | 0 | 0 | 1 | ovarian granulosa cell tumor | 0.4157773365202895 | |||
| P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Tier 1 | 0.661 | 1 | A2_pm_peripheral | 32 | 84.31 | 1 | 0 | 1 | 1 | 35921069 | 1 | multiple myeloma | 0.40496963397728575 | ||
| Q8N3R9 | PALS1 | Protein PALS1 | Tier 1 | 0.652 | 1 | A2_pm_peripheral | 9 | 77.19 | 1 | 0 | 0 | 0 | 1 | COVID-19 | 0.3720065057444545 | |||
| P06702 | S100A9 | Protein S100-A9 | Tier 1 | 0.651 | 1 | A2_pm_peripheral | 13 | 94.31 | 1 | 0 | 1 | 9 | 41924874, 41505229, 41477217, 40215752, 39317671, 37879125, 35724603, 33534888, 32478041 | 1 | inborn error of immunity | 0.36994943453938645 | ||
| Q92797 | SYMPK | Symplekin | Tier 1 | 0.651 | 1 | A2_pm_peripheral | 13 | 74.56 | 1 | 0 | 0 | 0 | 1 | dengue disease | 0.3695798546847018 | |||
| Q16658 | FSCN1 | Fascin | Tier 1 | 0.642 | 1 | A2_pm_peripheral | 28 | 94.19 | 1 | 0 | 0 | 0 | 1 | ankylosing spondylitis | 0.3390409466148633 | |||
| Q4FZB7 | KMT5B | Histone-lysine N-methyltransferase KMT5B | Tier 1 | 0.628 | 1 | A2_pm_peripheral | 10 | 54.91 | 1 | 0 | 0 | 0 | 0 | intellectual disability, autosomal dominant 51 | 0.7943209483524042 | |||
| Q5JVL4 | EFHC1 | EF-hand domain-containing protein 1 | Tier 1 | 0.626 | 1 | A2_pm_peripheral | 2 | 83.88 | 1 | 0 | 0 | 0 | 0 | juvenile myoclonic epilepsy | 0.7858434985198706 | |||
| Q15019 | SEPTIN2 | Septin-2 | Tier 1 | 0.621 | 1 | A2_pm_peripheral | 7 | 81.81 | 1 | 0 | 0 | 0 | 1 | osteoarthritis, hip | 0.2686294007302314 | |||
| Q9NPP4 | NLRC4 | NLR family CARD domain-containing protein 4 | Tier 1 | 0.619 | 1 | A2_pm_peripheral | 6 | 85.12 | 1 | 0 | 0 | 0 | 0 | periodic fever-infantile enterocolitis-autoinflammatory syndrome | 0.7635956406357429 | |||
| P10636 | MAPT | Microtubule-associated protein tau | Tier 1 | 0.618 | 1 | A2_pm_peripheral | 100 | 49.22 | 1 | 0 | 1 | 9 | 40380000, 39241336, 38585969, 38397086, 37003060, 31900535, 30004544, 29268187 | 0 | Pick disease | 0.7600399335134378 | ||
| P35716 | SOX11 | Transcription factor SOX-11 | Tier 1 | 0.614 | 1 | A2_pm_peripheral | 4 | 56.41 | 1 | 0 | 0 | 0 | 0 | intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism | 0.7470288070793535 | |||
| P41159 | LEP | Leptin | Tier 1 | 0.606 | 1 | A2_pm_peripheral | 10 | 81.12 | 1 | 0 | 1 | 14 | 40330320, 40008515, 39263947, 37331044, 36508319, 36173490, 35884340, 34016094, 33650854, 32527800, 27530235, 26529285, 23232067, 20594164 | 0 | obesity due to congenital leptin deficiency | 0.7197450249224271 | ||
| Q9Y5K8 | ATP6V1D | V-type proton ATPase subunit D | Tier 1 | 0.552 | 1 | A2_pm_peripheral | 8 | 86.25 | 1 | 0 | 0 | 0 | 1 | Alzheimer disease | 0.03916204989460526 | |||
| Q9BVS4 | RIOK2 | Serine/threonine-protein kinase RIO2 | Tier 1 | 0.552 | 1 | A2_pm_peripheral | 10 | 67.38 | 1 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.539818754658029 | |||
| Q9NXF7 | DCAF16 | DDB1- and CUL4-associated factor 16 | Tier 1 | 0.548 | 1 | A2_pm_peripheral | 2 | 38.19 | 1 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5251061120759617 | |||
| O43663 | PRC1 | Protein regulator of cytokinesis 1 | Tier 1 | 0.544 | 1 | A2_pm_peripheral | 6 | 78.94 | 1 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5139662839321523 | |||
| P43351 | RAD52 | DNA repair protein RAD52 homolog | Tier 1 | 0.528 | 1 | A2_pm_peripheral | 11 | 69.62 | 1 | 0 | 1 | 6 | 37288783, 32945515, 31495919, 26784987, 24500205, 23836560 | 0 | Abnormality of the skeletal system | 0.45994164258033876 | ||
| Q9UK80 | USP21 | Ubiquitin carboxyl-terminal hydrolase 21 | Tier 1 | 0.524 | 1 | A2_pm_peripheral | 4 | 69.75 | 1 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.44616960950164986 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;